Skip to content
ppharmaranks
Menu
Class IIOngoing

Lacosamide Oral Solution recall

FDA recall D-0457-2025 · initiated May 28, 2025

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Jun 11, 2025How we research

Apotex Corp. recalled Lacosamide Oral Solution in May 2025 — an FDA Class II recall (D-0457-2025) because Defective Container: This recall is being initiated due to a leaking unit stored horizontally.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Defective Container: This recall is being initiated due to a leaking unit stored horizontally.

Labelling, packaging or a product mix-up

The wrong information — or the wrong medicine — ended up in the pack. A mix-up is a manufacturing failure that can still be dangerous to swallow.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Batch # TZ5589, Exp Date: 01/31/2026

Quantity recalled: 20,648 bottles

Details

Product
Lacosamide Oral Solution, USP, 10 mg/mL, 200 mL, Rx Only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston FL 33326, NDC 60505-0405-4
Recalling company
Apotex
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
US Nationwide.
Initiated
May 28, 2025
FDA report date
Jun 11, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Lacosamide Oral Solution recalled?
Apotex Corp. recalled Lacosamide Oral Solution in May 2025 — an FDA Class II recall (D-0457-2025) because Defective Container: This recall is being initiated due to a leaking unit stored horizontally. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Lacosamide Oral Solution recalled?
Per the FDA enforcement record, the reason for recall D-0457-2025 was: Defective Container: This recall is being initiated due to a leaking unit stored horizontally.
Is a recalled Lacosamide Oral Solution dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Lacosamide Oral Solution are affected?
Distributed: US Nationwide.. The recall covers these lots — Batch # TZ5589, Exp Date: 01/31/2026. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0457-2025.

Source: openFDA Drug Enforcement record D-0457-2025

← All drug recalls